Myocardial infarction risk and tamoxifen therapy for breast cancer

Tamoxifen prevents recurrence after breast cancer and breast cancer among high-risk women, and may prevent myocardial infarction (MI). To assess the impact of tamoxifen on MI risk, we conducted a case–control study of first MI after breast cancer nested among women diagnosed with breast cancer, whil...

Descripción completa

Detalles Bibliográficos
Autores principales: Geiger, A M, Chen, W, Bernstein, L
Formato: Texto
Lenguaje:English
Publicado: Nature Publishing Group 2005
Materias:
Clinical Study
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2362055/
https://www.ncbi.nlm.nih.gov/pubmed/15841078
http://dx.doi.org/10.1038/sj.bjc.6602562

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2362055/
https://www.ncbi.nlm.nih.gov/pubmed/15841078
http://dx.doi.org/10.1038/sj.bjc.6602562

Ejemplares similares